Office of Biorepositories and Biospecimen Research, Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, MD 20892, USA.
Sci Transl Med. 2011 Feb 16;3(70):70cm5. doi: 10.1126/scitranslmed.3001742.
The National Institutes of Health (NIH) has long been known as an institution that supports biomedical advances through hypothesis-driven research. Another aspect of NIH, however, has received comparatively little attention and may be critical to advancing translational science beyond its current limitations. Specifically, this aspect of NIH focuses on supporting innovation through the development of high-risk technologies that have the potential to empower research.
美国国立卫生研究院（NIH）长期以来一直以通过假设驱动研究支持生物医学进展的机构而闻名。然而，NIH 的另一个方面相对较少受到关注，但对于推进转化科学超越当前的限制可能至关重要。具体来说，NIH 的这一方面侧重于通过开发有潜力为研究提供动力的高风险技术来支持创新。
